DR. ALAIN L. FYMAT, BA, BS, MA, MS, PhD, PhD, MYNAS, MEUAS is a medical-physical scientist and an educator. He is the current President/ CEO and Institute Professor at the International Institute of Medicine & Science with a previous appointment as Executive Vice President/Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine, both Institutes in California, U.S.A.
He was formerly Professor of Radiology, Radiological Sciences, Radiation Oncology, Critical Care Medicine, and Physics at several U.S. and European Universities. Earlier, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs (Office of Research Oversight). At the Loma Linda Veterans Affairs Medical Center, he was Scientific Director of Radiology, Director of the Magnetic Resonance Imaging Center and, for a time, Acting Chair of Radiology. Previously, he was Director of the Division of Biomedical and Biobehavioral Research at the University of California at Los Angeles/Drew University of Medicine and Science.
He was also Scientific Advisor to the U.S. National Academy of Sciences, National Research Council, for its postdoctoral programs tenable at the California Institute of Technology and Member of the Advisory Group for Research & Development, North Atlantic Treaty Organization (NATO). He is Health Advisor to the American Heart & Stroke Association, Coachella Valley Division, California.
He is a frequent Keynote Speaker and Organizing Committee member at several international scientific/medical conferences. He has lectured extensively in the U.S.A, Canada, Europe, Asia, and Africa. He has published in excess of 575 scholarly scientific publications and books. He is also Editor-in-Chief, Honorable Editor or Editor of numerous medical/scientific Journals to which he regularly contributes.
He is a member of the New York Academy of Sciences and the European Union Academy of Sciences, a Board member of several institutions, and a reviewer for the prestigious UNESCO Newton Prize, United Kingdom National Commission for UNESCO.
Dr. Fymat's current research interests are focused on neurodegenerative diseases (Alzheimer's, Parkinson's, dementias, epilepsy, multiple sclerosis, multiple system atrophy and others); oncology (glioblastoma); epigenetics & ecogenetics; nanomedicine & nanobiotechnology; infectious, fungal and parasitic diseases, including lyme, endemics, epidemics, and pandemics; epigenetics and ecogenetics; and physics. These are represented in part in his latest books:
“The Odyssey of Humanity's Diseases: Epigenetic and ecogenetic modulations from ancestry through inheritance, environment, culture, and behavior” Volumes 1, 2, and 3 (2020).
"Epigenetic Perspectives on Prevalent Human Diseases in Africa:
The Impact of Genomic Variability and the Environment on Disease Epigenesis"
(co-authored and co-edited with S. Singh and J. Kapalanga) (2023, in preparation).
“From the Heart to the Brain: My collected works in medical science research (2016-2018)” (2019).
“The Human Brain: Wonders and disorders” (2021).
"Glioblastoma: Management and Treatment" (an e-Book) (2017).
“Cancer: The pernicious, clonally-evolving disease braided in our genome” (2021).
"Nanomedicine: My collected works in nanomedicine research (2018-2021)“ (2021).
"Lyme disease: The great invader, evader, and imitator" (2020).
"Pandemics: Prescription for Prediction and Prevention" (2021).
"COVID-19: Perspectives across Africa" (co-authored and co-edited with NRA Romm and J. Kapalanga) (2022).
“Alzhei ...Who? Demystifying the disease and what you can do about it” (2019).
“Parkin..ss..oo..nn: Elucidating the disease and what you can do about it” (2020).
“Dementia: Fending-off the menacing disease and what you can do about it” (2020).
"Epilepsy: The electrical storm in the brain" (2022).
"Multiple sclerosis: The debilitating autoimmune disease " (2023).
"Multiple System Atrophy: The chronic, progressive, neurodegenerative synucleinopathic disease" (2023).
"Tourette: The self-under-siege neurodevelopmental and neuropsychiatric motor syndrome" (2023).
(For further particulars, please click on the following tabs: Clinical trials, Blogs, Podcasts, LinkedIn posts, Conferences, Patents, Books & Monographs, Book Contributions, Refereed Articles, and Abstracts.)